PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Departmentof Biochemistry and Biotechnology, Cell and Molecular Therapeutics Laboratory, Oriental Institute of Science and Technology, Midnapore, India; Founder and Secretary, Agricure Biotech Research Society, Epidemiology and Human Health Division, Midnapore 721101, India. Electronic address: maitism@rediffmail.com.\', \'Departmentof Biochemistry and Biotechnology, Cell and Molecular Therapeutics Laboratory, Oriental Institute of Science and Technology, Midnapore, India. Electronic address: bamrita.bioinfo@gmail.com.\', \'Departmentof Biochemistry and Biotechnology, Cell and Molecular Therapeutics Laboratory, Oriental Institute of Science and Technology, Midnapore, India.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1537-1891(21)00028-810.1016/j.vph.2021.106856
?:hasPublicationType
?:journal
  • Vascular pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33746069
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.352
?:rankingScore_hIndex
  • 83
is ?:relation_isRelatedTo_publication of
?:title
  • In silico Nigellidine (N. sativa) bind to viral spike/active-sites of ACE1/2, AT1/2 to prevent COVID-19 induced vaso-tumult/vascular-damage/comorbidity.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33746069>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33746069>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all